Poor glycemic control is associated with abnormal changes in 24-hour ambulatory blood pressure in children and adolescents with type 1 diabetes mellitus

Journal of Pediatric Endocrinology and Metabolism

Volumn 22, Issue 11, 2009, Pages 1061-1067

  Chatterjee, Manjula ^a,b   Speiser, Phyllis W ^a   Pellizzarri, Margaret ^a   Carey, Dennis E ^a   Fort, Pavel ^a   Kreitzer, Paula M ^a   Frank, Graeme R ^a  

^a SCHNEIDER CHILDREN'S HOSPITAL   (United States)

^b BROOKLYN HOSPITAL CENTER   (United States)

Author keywords

Ambulatory blood pressure; Hypertension

Indexed keywords

HEMOGLOBIN A1C;

ADOLESCENT; AGE DISTRIBUTION; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; CONTROLLED STUDY; DIABETES CONTROL; DIABETIC PATIENT; DISEASE DURATION; FAMILY HISTORY; FEMALE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

EID: 75749093018     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2009.22.11.1061     Document Type: Article

References (50)

1. Christlieb AR, Warram JH, Krolewski AS, et al. Hypertension: the major risk factor in juvenile-onset insulin-dependent diabetics. Diabetes 1981; 30 (Suppl 2): 90-96.
2. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329: 977-986.
3. Lurbe E, Redon J, Kesani A, et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 2002; 347: 797-805.
4. Krolewski AS, Canessa M, Warram JH, et al. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 1988; 318: 140-145.
5. Mogensen CE. Urinary albumin excretion in early and long-term juvenile diabetes. Scand J Clin Lab Invest 1971; 28: 183-193.
6. Garg SK, Chase HP, Icaza G, Rothman RL, Osberg I, Carmain JA. 24-hour ambulatory blood pressure and renal disease in young subjects with type I diabetes. J Diabetes Complications 1997; 11: 263-267.
7. Poulsen PL, Hansen KW, Mogensen CE. Ambulatory blood pressure in the transition from normo- to microalbuminuria. A longitudinal study in IDDM patients. Diabetes 1994; 43: 1248-1253.
8. 1c, hypertension, dyslipidemia, diabetes onset, and sex. Diabetes Care 2007; 30: 2523-2528.
9. Torbjornsdotter TB, Jaremko GA, Berg UB. Non-dipping and its relation to glomerulopathy and hyperfiltration in adolescents with type 1 diabetes. Diabetes Care 2004; 27: 510-516.
10. Barzilay J, Warram JH, Bak M, Laffel LM, Canessa M, Krolewski AS. Predisposition to hypertension: risk factor for nephropathy and hypertension in IDDM. Kidney Int 1992; 41: 723-730.
11. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114 (Suppl 4th Report): 555-576.
12. Sinaiko AR, Gomez-Marin O, Prineas RJ. Prevalence of " significant" hypertension in junior high school-aged children: the Children and Adolescent Blood Pressure Program. J Pediatr 1989; 114: 664-669.
13. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Pediatrics 1996; 98: 649-658.
14. Knerr I, Dost A, Lepler R, et al. Tracking and prediction of arterial blood pressure from childhood to young adulthood in 868 patients with type 1 diabetes: a multicenter longitudinal survey in Germany and Austria. Diabetes Care 2008; 31: 726-727.
15. Norgaard K, Feldt-Rasmussen B, Borch-Johnsen K, Saelan H, Deckert T. Prevalence of hypertension in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1990; 33: 407-410.
16. Hinderliter AL, Runge MS. Who's on first? Does hypertension in type I diabetics result from nephropathy or metabolic alterations? Circulation 2001; 104: 508-510.
17. Brands MW, Hopkins TE. Poor glycemic control induces hypertension in diabetes mellitus. Hypertension 1996; 27: 735-739.
18. Schultz CJ, Neil HA, Dalton RN, Konopelska BT, Dunger DB. Blood pressure does not rise before the onset of microalbuminuria in children followed from diagnosis of type 1 diabetes. Oxford Regional Prospective Study Group. Diabetes Care 2001; 24: 555-560.
19. Crompton CH, Balfe JW, Balfe JA, Chatzilias A, Daneman D. Sodium-lithium transport in adolescents with IDDM. Relationship to incipient nephropathy and glycemic control. Diabetes Care 1994; 17: 704-710.
20. Rudberg S, Persson B, Dahlquist G. Increased glomerular filtration rate as a predictor of diabetic nephropathy-an 8-year prospective study. Kidney Int 1992; 41: 822-828.
21. Pickering TG, Gerin W, Schwartz AR. What is the white-coat effect and how should it be measured? Blood Press Monit 2002; 7: 293-300.
22. Julius S, Jamerson K, Gudbrandsson T, Schork N. White coat hypertension: a follow-up. Clin Exp Hypertens A 1992; 14: 45-53.
23. Sorof JM, Portman RJ. Ambulatory blood pressure measurements. Curr Opin Pediatr 2001; 13: 133-137.
24. Waeber G, Waeber B, Nussberger J, Brunner HR. Ambulatory blood pressure monitoring in adolescent untreated hypertensive patients. Clin Exp Hypertens A 1986; 8: 611-614.
25. Kain HK, Hinman AT, Sokolow M. Arterial blood pressure measurements with a portable recorder in hypertensive patients. I. Variability and correlation with "casual" pressures. Circulation 1964; 30: 882-892.
26. Soergel M, Kirschstein M, Busch C, et al. Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr 1997; 130: 178-184.
27. Verdecchia P. White-coat hypertension in adults and children. Blood Press Monit 1999; 4: 175-179.
28. Pietrzak I, Szadkowska A, Czerniawska E, Mianowska B, Bodalska-Lipinska J, Bodalski J. [Prehypertension risk factors in children and adolescents with type 1 diabetes]. Przegl Lek 2006; 63 (Suppl 3): 111-114.
29. Szadkowska A, Pietrzak I, Mianowska B, et al. [Prehypertension in type 1 diabetic children and adolescents]. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw 2006; 12: 286-291.
30. Dost A, Klinkert C, Kapellen T, et al. Arterial hypertension determined by ambulatory blood pressure profiles: contribution to microalbuminuria risk in a multicenter investigation in 2,105 children and adolescents with type 1 diabetes. Diabetes Care 2008; 31: 720-725.
31. Lafferty AR, Werther GA, Clarke CF. Ambulatory blood pressure, microalbuminuria, and autonomic neuropathy in adolescents with type 1 diabetes. Diabetes Care 2000; 23: 533-538.
32. Sega R, Facchetti R, Bombelli M, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005; 111: 1777-1783.
33. Simckes AM, Srivastava T, Alon US. Ambulatory blood pressure monitoring in children and adolescents. Clin Pediatr (Phila) 2002; 41: 549-564.
34. Falkner B, Gidding SS, Portman R, Rosner B. Blood pressure variability and classification of prehypertension and hypertension in adolescence. Pediatrics 2008; 122: 238-242.
35. Diaz LN, Garin EH. Comparison of ambulatory blood pressure and Task Force criteria to identify pediatric hypertension. Pediatr Nephrol 2007; 22: 554-558.
36. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures. JAMA 1983; 249: 2792-2798.
37. Holl RW, Pavlovic M, Heinze E, Thon A. Circadian blood pressure during the early course of type 1 diabetes. Analysis of 1,011 ambulatory blood pressure recordings in 354 adolescents and young adults. Diabetes Care 1999; 22: 1151-1157.
38. Metoki H., Ohkubo T, Kikuya M, et al. Prognostic significance of night-time, early morning, and day-time blood pressure on the risk of cerebrovascular and cardiovascular mortality: Ohasama Study. J Hypertens 2006; 24: 1841-1848.
39. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340: 14-22.
40. Sochett EB, Poon I, Balfe W, Daneman D. Ambulatory blood pressure monitoring in insulin-dependent diabetes mellitus adolescents with and without microalbuminuria. J Diabetes Complications 1998; 12: 18-23.
41. Daniels SR. Hypertension-induced cardiac damage in children and adolescents. Blood Press Monit 1999; 4: 165-170.
42. Harshfield GA, Alpert BS, Pulliam DA, Somes GW, Wilson DK. Ambulatory blood pressure recordings in children and adolescents. Pediatrics 1994; 94: 180-184.
43. Urbina E, Alpert B, Flynn J, et al. Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the council on cardiovascular disease in the young and the council for high blood pressure research. Hypertension 2008; 52: 433-451.
44. Zhang Y, Lee ET, Devereux RB, et al. Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study. Hypertension 2006; 47: 410-414.
45. Guntsche Z, Saravi FD, Reynals EA, Rauek B, Rauek M, Guntsche EM. Parental hypertension and 24 h-blood pressure in children prior to diabetic nephropathy. Pediatr Nephrol 2002; 17: 157-164.
46. Pellicia P, Savino A, Cecamore C, Primavera A, Schiavone C, Chiarelli F. Early changes in renal hemodynamics in children with diabetes: Doppler sonographic findings. J Clin Ultrasound 2008; 36: 335-340.
47. Holl RW, Rehm R, Walker P, Heinze E. [24-hour blood pressure measurement in children and adults with type I diabetes mellitus: relation to duration of diabetes, obesity, albuminuria]. Z Kardiol 1992; 81 (Suppl 2): 25-27.
48. Schmieder RE. Nephroprotection by antihypertensive agents. J Cardiovasc Pharmacol 1994; 24 (Suppl 2): S55-S64.
49. Scarsi KK, Bjornson DC. The use of ACE inhibitors as renoprotective agents in Medicaid patients with diabetes. Ann Pharmacother 2000; 34: 1002-1006.
50. American Diabetes Association. Position Statement - Standards of Medical Care in Diabetes. Diabetes Care 2009; 32: S13-S19.